Gilead sues Lupin over proposed generic of Symtuza HIV drug

Gilead Sciences Inc has said an Indian generic drugmaker's proposed version of the HIV drug Symtuza infringes its patents, in a lawsuit in ...


View article...


Top stories of the last 30 days